Payment overview · 2025
General Payments
$241.00
10 reported records · 8 companies
Healthcare provider profile · identity verified
Mikhail Losif Azrilevich, MD
Allopathic & Osteopathic Physicians|Internal Medicine · PHILADELPHIA, PA · NPI 1598749178
Verified facts
What the public records show
CMS Open Payments records show Mikhail Losif Azrilevich, MD received $241.00 in general payments during 2025 across 10 reported records.
PFIZER INC. accounted for 28.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 15 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Gemtesa, Mounjaro, Ozempic.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 280 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 38 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 87 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 189 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 686 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Paxlovid by this doctor in 2024.
Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported GEMTESA as an associated drug or biological on 61692 records involving 22152 distinct recipient NPIs. Public Medicare Part D data also shows 145 claims for Gemtesa by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $67.86 | 28.2% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $34.81 | 14.4% | 1 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $28.64 | 11.9% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $26.09 | 10.8% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $25.19 | 10.4% | 1 | 2025 |
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $24.32 | 10.1% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $18.96 | 7.9% | 1 | 2025 |
| Kowa Pharmaceuticals America, Inc. | Unresolved — no canonical attribution shown | $15.13 | 6.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $241.00 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $49.43 | 2 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $49.43 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $34.81 | 1 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $28.64 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $26.09 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $26.09 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $25.19 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $25.19 | 1 | 2025 |
Source payment records
|
|||||
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $24.32 | 1 | 2025 |
Source payment records
|
|||||
| VERQUVO Normalized: verquvo |
Drug | Merck Sharp & Dohme LLC | $18.96 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $18.43 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $18.43 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $18.43 | 1 | 2025 |
Source payment records
|
|||||
| TRUMENBA Normalized: trumenba |
Biological | PFIZER INC. | $18.43 | 1 | 2025 |
Source payment records
|
|||||
| ZORYVE Normalized: zoryve |
Drug | Kowa Pharmaceuticals America, Inc. | $15.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| GEMTESA gemtesa |
2025 | Gemtesa | 2024 | 145 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 38 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 189 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
280 | 57 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
38 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
87 | 14 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
189 | 29 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
686 | 84 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
31 | 31 |
| Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference |
2025 | GEMTESA open payments reported associated product |
CMS Open Payments — General Payments 61692 supporting records · 22152 recipient NPIs · example record 1176593503 |
Gemtesa · 2024 Exact normalized brand match · 1 Part D row |
145 | 21 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 2674 | 345 |
| Atorvastatin Calcium | Atorvastatin Calcium | 2284 | 335 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1919 | 239 |
| Metformin Hcl | Metformin Hcl | 1822 | 228 |
| Losartan Potassium | Losartan Potassium | 1595 | 225 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1578 | 180 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1456 | 163 |
| Metoprolol Succinate | Metoprolol Succinate | 1311 | 168 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1295 | 136 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1294 | 183 |
| Furosemide | Furosemide | 1278 | 146 |
| Omeprazole | Omeprazole | 1267 | 142 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1035 | 130 |
| Gabapentin | Gabapentin | 934 | 110 |
| Atenolol | Atenolol | 883 | 104 |
| Fluticasone Propionate | Fluticasone Propionate | 828 | 130 |
| Linzess | Linaclotide | 825 | 94 |
| Carvedilol | Carvedilol | 804 | 101 |
| Diclofenac Sodium | Diclofenac Sodium | 801 | 129 |
| Valsartan | Valsartan | 748 | 98 |
| Clonidine Hcl | Clonidine Hcl | 722 | 108 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 722 | 76 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 722 | 98 |
| Lisinopril | Lisinopril | 715 | 106 |
| Potassium Chloride | Potassium Chloride | 713 | 75 |
| Eliquis | Apixaban | 686 | 84 |
| Hydrochlorothiazide | Hydrochlorothiazide | 634 | 89 |
| Vascepa | Icosapent Ethyl | 632 | 66 |
| Ibuprofen | Ibuprofen | 614 | 112 |
| Creon | Lipase/Protease/Amylase | 563 | 67 |
| Allopurinol | Allopurinol | 542 | 71 |
| Hydralazine Hcl | Hydralazine Hcl | 535 | 72 |
| Glimepiride | Glimepiride | 534 | 74 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 524 | 69 |
| Donepezil Hcl | Donepezil Hcl | 518 | 58 |
| Clopidogrel | Clopidogrel Bisulfate | 500 | 67 |
| Doxazosin Mesylate | Doxazosin Mesylate | 481 | 54 |
| Ipratropium Bromide | Ipratropium Bromide | 474 | 91 |
| Memantine Hcl Er | Memantine Hcl | 452 | 55 |
| Famotidine | Famotidine | 434 | 50 |
| Nitroglycerin | Nitroglycerin | 423 | 67 |
| Alendronate Sodium | Alendronate Sodium | 417 | 44 |
| Ventolin Hfa | Albuterol Sulfate | 411 | 54 |
| Meloxicam | Meloxicam | 403 | 65 |
| Farxiga | Dapagliflozin Propanediol | 392 | 66 |
| Nifedipine Er | Nifedipine | 384 | 48 |
| Alprazolam | Alprazolam | 376 | 54 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 374 | 92 |
| Simvastatin | Simvastatin | 374 | 46 |
| Sertraline Hcl | Sertraline Hcl | 372 | 58 |
| Zolpidem Tartrate | Zolpidem Tartrate | 372 | 71 |
| Ezetimibe | Ezetimibe | 365 | 49 |
| Pravastatin Sodium | Pravastatin Sodium | 331 | 37 |
| Trazodone Hcl | Trazodone Hcl | 324 | 37 |
| Colchicine | Colchicine | 322 | 41 |
| Synthroid | Levothyroxine Sodium | 321 | 29 |
| Tradjenta | Linagliptin | 305 | 38 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 302 | 46 |
| Dexlansoprazole Dr | Dexlansoprazole | 291 | 37 |
| Montelukast Sodium | Montelukast Sodium | 290 | 38 |
| Jardiance | Empagliflozin | 280 | 57 |
| Tizanidine Hcl | Tizanidine Hcl | 278 | 41 |
| Clonazepam | Clonazepam | 277 | 31 |
| Finasteride | Finasteride | 271 | 33 |
| Celecoxib | Celecoxib | 267 | 39 |
| Procto-Med Hc | Hydrocortisone | 259 | 46 |
| Ranolazine Er | Ranolazine | 254 | 26 |
| Mirtazapine | Mirtazapine | 251 | 28 |
| Ketoconazole | Ketoconazole | 238 | 46 |
| Meclizine Hcl | Meclizine Hcl | 238 | 48 |
| Januvia | Sitagliptin Phosphate | 232 | 37 |
| Memantine Hcl | Memantine Hcl | 222 | 26 |
| Quetiapine Fumarate | Quetiapine Fumarate | 206 | 29 |
| Xarelto | Rivaroxaban | 203 | 32 |
| Azithromycin | Azithromycin | 202 | 170 |
| Azelastine Hcl | Azelastine Hcl | 201 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 200 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 200 | 26 |
| Ammonium Lactate | Ammonium Lactate | 199 | 37 |
| Breo Ellipta | Fluticasone/Vilanterol | 198 | 23 |
| Ibu | Ibuprofen | 194 | 36 |
| Glipizide | Glipizide | 191 | 20 |
| Myrbetriq | Mirabegron | 191 | 31 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 190 | 28 |
| Irbesartan | Irbesartan | 190 | 18 |
| Ozempic | Semaglutide | 189 | 29 |
| Chlorthalidone | Chlorthalidone | 183 | 17 |
| Lidocaine | Lidocaine | 183 | 29 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 182 | 27 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 181 | 24 |
| Temazepam | Temazepam | 173 | 30 |
| Mupirocin | Mupirocin | 171 | 47 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 168 | 51 |
| Bumetanide | Bumetanide | 166 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 165 | 17 |
| Baclofen | Baclofen | 163 | 26 |
| Labetalol Hcl | Labetalol Hcl | 158 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 153 | 30 |
| Spironolactone | Spironolactone | 152 | 22 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 152 | 15 |
| Gemtesa | Vibegron | 145 | 21 |
| Loperamide | Loperamide Hcl | 145 | 27 |
| Icosapent Ethyl | Icosapent Ethyl | 144 | 31 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 136 | 42 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 134 | 23 |
| Proctozone-Hc | Hydrocortisone | 132 | 33 |
| Nitroglycerin Patch | Nitroglycerin | 129 | 16 |
| Warfarin Sodium | Warfarin Sodium | 128 | 11 |
| Lorazepam | Lorazepam | 127 | 26 |
| Glipizide Er | Glipizide | 118 | 12 |
| Cefuroxime | Cefuroxime Axetil | 117 | 82 |
| Tramadol Hcl | Tramadol Hcl | 116 | 32 |
| Lansoprazole | Lansoprazole | 113 | 17 |
| Dutasteride | Dutasteride | 109 | 12 |
| Methylprednisolone | Methylprednisolone | 109 | 95 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 106 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 11 |
| Clotrimazole | Clotrimazole | 102 | 28 |
| Fenofibrate | Fenofibrate Nanocrystallized | 100 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 97 | 11 |
| Alcohol Pads | Alcohol Antiseptic Pads | 94 | 23 |
| Nebivolol Hcl | Nebivolol Hcl | 93 | 16 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 92 | 22 |
| Metformin Hcl Er | Metformin Hcl | 91 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 90 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 88 | 13 |
| Trulicity | Dulaglutide | 87 | 14 |
| Prednisone | Prednisone | 86 | 34 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 84 | 72 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 83 | 30 |
| Hydrocortisone | Hydrocortisone | 82 | 20 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 82 | 12 |
| Zenpep | Lipase/Protease/Amylase | 82 | 11 |
| Restasis | Cyclosporine | 78 | suppressed |
| Digoxin | Digoxin | 76 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 66 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 66 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 64 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 63 | suppressed |
| Cilostazol | Cilostazol | 62 | suppressed |
| Nystatin | Nystatin | 62 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 59 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 57 | 55 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 57 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 56 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 56 | 12 |
| Ramipril | Ramipril | 56 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 55 | suppressed |
| Lovastatin | Lovastatin | 55 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 55 | 14 |
| Sotalol | Sotalol Hcl | 55 | suppressed |
| Brilinta | Ticagrelor | 54 | suppressed |
| Ciclopirox | Ciclopirox | 54 | suppressed |
| Risperidone | Risperidone | 54 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 52 | 20 |
| Pentoxifylline | Pentoxifylline | 52 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 50 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 49 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 47 | suppressed |
| Levetiracetam | Levetiracetam | 45 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 45 | suppressed |
| Entresto | Sacubitril/Valsartan | 44 | 11 |
| Latanoprost | Latanoprost | 43 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 42 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 42 | 12 |
| Torsemide | Torsemide | 42 | suppressed |
| Clonidine | Clonidine | 41 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 41 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 41 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | 32 |
| Single Use Swab | Alcohol Antiseptic Pads | 40 | 12 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 39 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 38 | suppressed |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Ssd | Silver Sulfadiazine | 38 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 37 | suppressed |
| Invokana | Canagliflozin | 37 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 37 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 30 |
| Naproxen | Naproxen | 36 | 15 |
| Valacyclovir | Valacyclovir Hcl | 35 | 19 |
| Jentadueto | Linagliptin/Metformin Hcl | 34 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 33 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 32 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 31 | 31 |
| Calcitriol | Calcitriol | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | 13 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 28 | suppressed |
| Methimazole | Methimazole | 28 | suppressed |
| Metolazone | Metolazone | 28 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 27 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 26 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Ursodiol | Ursodiol | 25 | suppressed |
| Cephalexin | Cephalexin | 24 | 19 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 24 | suppressed |
| Mesalamine | Mesalamine | 24 | suppressed |
| Repaglinide | Repaglinide | 24 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 23 | suppressed |
| Lactulose | Lactulose | 23 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 23 | 14 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 23 | suppressed |
| Zaleplon | Zaleplon | 23 | suppressed |
| Endocet | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Fluocinonide | Fluocinonide | 21 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 20 | 15 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Metronidazole | Metronidazole | 20 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 20 | 18 |
| Nexium | Esomeprazole Magnesium | 20 | suppressed |
| Rivastigmine | Rivastigmine | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 19 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Crestor | Rosuvastatin Calcium | 16 | suppressed |
| Nyamyc | Nystatin | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 16 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 15 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Dexilant | Dexlansoprazole | 15 | suppressed |
| Niacin Er | Niacin | 15 | suppressed |
| Renvela | Sevelamer Carbonate | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Budesonide Ec | Budesonide | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Trueplus Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 14 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 13 | 13 |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Mitigare | Colchicine | 13 | suppressed |
| Multaq | Dronedarone Hcl | 13 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 13 | suppressed |
| Pimecrolimus | Pimecrolimus | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Trulance | Plecanatide | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Edarbyclor | Azilsartan Med/Chlorthalidone | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Flomax | Tamsulosin Hcl | 12 | suppressed |
| Glipizide Xl | Glipizide | 12 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Dofetilide | Dofetilide | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Nateglinide | Nateglinide | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $241.00 · 10 records | PFIZER INC. | ABRYSVO, COMIRNATY, Cologuard Collection Kit, GEMTESA, INSPIRE, MOUNJARO, NURTEC ODT, Ozempic, PREVNAR 20, Rybelsus, TRUMENBA, VERQUVO, ZAVZPRET, ZEPBOUND, ZORYVE | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Gemtesa play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error